SANGAMO BIOSCIENCES INC
Net SellingSGMO·US·🇺🇸 US
16%buys·84%sales
2,690 transactions$152.1MTotal buys·226 buys
$304.5MTotal sells·1,204 sells
5252 insiders
Last: Apr 1, 2026
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Apr 1, 26 | Macrae Sandy | Grant | - | |
| Apr 1, 26 | Davis Gregory D | Grant | - | |
| Apr 1, 26 | Willoughby Scott B. | Grant | - | |
| Apr 1, 26 | Dubois-Stringfellow Nathalie | Grant | - | |
| Apr 1, 26 | Jain Nikunj | Grant | - | |
| Nov 24, 25 | Davis Gregory D | Other | $304 | |
| Nov 24, 25 | Dubois-Stringfellow Nathalie | Other | $1K | |
| Nov 24, 25 | Duraibabu Prathyusha | Other | $1K | |
| Nov 24, 25 | Macrae Sandy | Other | $3K | |
| Nov 24, 25 | Willoughby Scott B. | Other | $855 |
SANGAMO BIOSCIENCES INC (SGMO) has recorded 2 690 insider transactions from 52 insiders. Total insider buying volume stands at $152.1M, while total selling volume is $304.5M. Overall insider sentiment is bearish (84% sales).
SANGAMO BIOSCIENCES INC (SGMO) has recorded 2 690 insider operations, including 226 open-market purchases ($152.1M), 1 204 sales ($304.5M) and 1 260 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bearish (84% sales).
Insider activity at SANGAMO BIOSCIENCES INC is sustained, with operations recorded in 8 of the last 12 months — a sign of regular regulatory filings.
Among the most active insiders are LANPHIER EDWARD O II (CEO), Macrae Sandy (CEO) & Wolff Henry Ward (CFO), with respectively 437, 42, 190 transactions.
Across all 2 690 recorded transactions, the breakdown by type is: sales (1204, 45%), exercise (646, 24%), grant (386, 14%), buys (226, 8%), tax (186, 7%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
SANGAMO BIOSCIENCES INC has recorded 2 690 insider operations in total, including 226 open-market purchases ($152.1M), 1 204 sales ($304.5M) and 1 260 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on April 1, 2026.
Insiders at SANGAMO BIOSCIENCES INC are currently net sellers, with 16% purchases and 84% sales across all reported transactions. Total buy volume is $152.1M versus $304.5M in sales, indicating a bearish insider sentiment.
InsiderLens tracks 52 insiders at SANGAMO BIOSCIENCES INC (SGMO). LANPHIER EDWARD O II (CEO, 437 tx), Macrae Sandy (CEO, 42 tx), Wolff Henry Ward (CFO, 190 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for SGMO is bearish, based on a 16% buy ratio across 1 430 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for SANGAMO BIOSCIENCES INC comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.